State-of-the-art 3T MRI and cutting-edge molecular imaging are fully integrated as one. Only Siemens makes the simultaneous acquisition of whole-body MR and PET possible. Molecular MR supports our ...

Novartis noted that a dedicated diagnostics owner would better support molecular imaging's growth prospects, leading to this ...

Our company has built a foundation on delivering innovative, high-quality PET scanners to our customers worldwide, and the ...

Cubresa is pleased to announce that it has signed a global Master Interface Agreement with Siemens Healthineers. The agreement is a broad contract designed to support development efforts and ...

Our molecular Imaging business is on a very exciting growth ... With respect to us, Siemens Healthineers, we have a globally well-spread value-add structure; two of our four segments are ...

Detection tech experts Kromek Group say they will move back into profit after a huge new agreement with Siemens.

In a report released today, Sam England from Berenberg Bank maintained a Buy rating on Siemens Healthineers AG (SEMHF – Research Report), with ...

The report provides insights into Siemens Healthineers' tech activities, including its digital transformation strategies, its innovation programs, and its technology initiatives.Dublin, Feb. 04, 2025 ...

The company said that growth in its diagnostics business was partly offset by declines in the Americas and China.

UBS analyst Graham Doyle maintained a Hold rating on Siemens Healthineers AG (SEMHF – Research Report) today and set a price target of €53.00.